Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in youngsters and individuals. In Canada, its distribution is overseen by Health https://sandozlisdexamfetamineon444219.blogsumer.com/41963892/this-medication-in-canada-a-detailed-guide